Tesamorelin

Product Overview

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), developed to interact with specific receptors involved in growth hormone regulation. It has gained attention in scientific research for its role in endocrine signalling, metabolic processes and growth hormone-related pathways.

Tesamorelin is of particular interest in research exploring the relationship between growth hormone secretion, lipid metabolism and body composition.

Its targeted interaction with GHRH receptors makes it a valuable compound for controlled laboratory investigations into hormonal regulation and metabolic function.

Manufacturing

Tesamorelin can be synthesised using advanced solid-phase peptide synthesis (SPPS) techniques to achieve precise molecular structure, high purity and consistency.

Each batch undergoes independent third-party testing to assess peptide identity and purity, with laboratory results.

The peptide is carefully handled and packaged to help maintain product integrity throughout storage and transport.

Research Applications

Tesamorelin is commonly studied in scientific research exploring:

• Growth Hormone Regulation: Investigation of growth hormone-releasing hormone receptors and associated signalling pathways.

• Metabolic Research: Examination of growth hormone-related mechanisms involved in energy metabolism and metabolic regulation.

• Lipid Metabolism: Research into pathways associated with fat metabolism and lipid regulation.

• Body Composition Research: Investigation of the relationship between growth hormone signalling and adipose tissue distribution.

• Endocrine Function: Studies examining hormonal communication, receptor activity and physiological regulatory mechanisms.

Disclaimer

For research purposes only. Not for human consumption.